Health care services upstart Hims & Hers continues its growth streak during the company’s fiscal second quarter, as both revenue and subscribers increased by double digits year over year.
In Him & Hers’ Q2 earnings, the company reported revenue of $544.8 million, up 73% over the same period last year. Meanwhile, Hims & Hers’ subscriber count grew to over 2.4 million, up 31% year over year. This includes a 73,000 subscriber increase from Q1 to Q2 this year. The company confirmed expected full-year 2025 revenue guidance of $2.3 billion to $2.4 billion.
Hims & Hers, founded in 2017, is a direct-to-consumer telehealth company that provides online medical consultations and prescription medications. The company was North America’s fastest-growing online retailer by web sales growth from 2024 in Digital Commerce 360’s 2025 edition of the Top 1000 Report.
Hims & Hers web sales by year
Hims & Hers revenue growth amid GLP-1 dispute
“We believe we’re entering an exciting period of growth where we’ll enter new, high-impact specialties that bring millions of people in need of care into the market,” said Andrew Dudum, co-founder and CEO at Hims & Hers, during an earnings call with investors. “We expect this broadening offering will transform our platform from a place where customers come to solve a single issue, to one where customers can proactively manage their overall health.”
In June, the pharmaceutical company Novo Nordisk announced it was ending a collaboration with Hims & Hers to sell its weight loss drug Wegovy. The disagreement centered around sales of similar glucagon-like peptide 1 (GLP-1) products sold by Hims & Hers. Despite the GLP-1 dispute and ongoing regulatory discussions about the drugs, Hims & Hers maintains it will grow in other categories, citing dermatology and sexual health as growth areas.
Dudum said expanding access to personalized treatment options and a wide array of tools allowed Hims & Hers to attract new subscribers to the platform — and resulted in stronger retention. He also noted that the customers they do have for GLP-1 drugs tend to stick with the treatment longer than those who try the medicine through other means.
“At 6 months, only 25% of customers on our platform had discontinued treatment,” Dudum said, citing studies that show most people — 80% — drop off the drugs after six months.
The company also touted its purchase of European telehealth company Zava and announced plans to expand into the Canadian market in 2026.
Market dynamics making Hims & Hers’ growth possible
Eric Bormel, a director in health care focused on the consumer health technology sector at the firm Solomon Partners, said changes in how consumers seek health care have opened up opportunities for Hims & Hers. Moreover, he noted that the surge in Hims & Hers’ growth is emblematic of a broader transformation taking place.
“Patients are no longer passive recipients — they’re active participants, choosing providers and experiences — in the case of Hims & Hers, based on convenience, price and anonymity,” Bormel stated.
He added that other direct-to-consumer winners are aligning toward concierge-level care, focused on longitudinal relationships, longevity-driven solutions and personalized experiences.
“This is forcing incumbents to rethink everything from care delivery to patient engagement,” Bormel said.
Moreover, Bormel assessed that as more consumers embrace cash-pay models, continued growth may follow in asynchronous care, AI-driven diagnostics, and direct-to-consumer therapeutics across consumer-oriented health care verticals such as women’s health, sexual health and metabolic health.
“It is exciting to see innovation that enables health care to transform from just a service, to treating it as a product — designed, priced and delivered with the consumer in mind,” Bormel stated.
Do you rank in our databases?
Submit your data and we’ll see where you fit in our next ranking update.
Sign up
Stay on top of the latest developments in the online retail industry. Sign up for a complimentary subscription to Digital Commerce 360 Retail News. Follow us on LinkedIn, X (formerly Twitter), Facebook and YouTube. Be the first to know when Digital Commerce 360 publishes news content.
